Causal Ensemble Modeling for Small-Sample Clinical Subpopulation Discovery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for identifying subpopulations in clinical studies face challenges in accurately computing Conditional Average Treatment Effect (CATE), particularly in exploratory phases with small sample sizes, leading to variability in treatment effects and skepticism about results.

Innovation Solution

A method using a causal ensemble model integrating at least two different causal predictive models to compute eCATE, leveraging models like causal forests, meta-learners, and other machine learning techniques to identify subpopulations and understand treatment mechanisms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If multiple different causal predictive models are integrated into an ensemble model, then the reliability and precision of CATE estimation is improved, but the device complexity and computational requirements increase

Engineering Contradiction:
ImproveCATE estimation precisionVSAvoidmodel integration complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent combines multiple causal predictive models (e.g., causal forests, meta-learners, and other machine learning techniques) into a single ensemble model framework. This merging approach allows the system to leverage the strengths of different models simultaneously, improving CATE estimation precision by capturing diverse patterns in the data that single models might miss.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The ensemble model framework is designed to be universal, accommodating multiple types of causal predictive models within a single unified system. This multi-functionality allows the same framework to handle different model architectures and algorithms, reducing the need for separate systems while maintaining high estimation precision across various scenarios.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Ease of operation

If exploratory clinical phases use small sample sizes, then the ease of operation and study feasibility is improved, but the reliability of subpopulation identification deteriorates

Engineering Contradiction:
Improvestudy feasibilityVSAvoidsubpopulation identification reliability
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent transforms the approach to handling small sample sizes by changing the methodological parameters - using ensemble modeling and sophisticated causal inference techniques that are particularly effective in low-sample regimes. This allows reliable subpopulation identification even when traditional methods would fail due to insufficient data.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The ensemble model acts as a composite approach, combining multiple predictive models to create a more robust estimation system. This composite methodology compensates for the limitations of small sample sizes by aggregating information across different model perspectives, thereby improving reliability without requiring larger sample sizes.

Inventive Principle:
Principle #40Composite materials

3Loss of information

If traditional CATE analysis methods are applied to wide data with many covariates, then the completeness of feature analysis is improved, but the difficulty of detecting and measuring treatment effects increases

Engineering Contradiction:
Improvefeature information completenessVSAvoidtreatment effect detection difficulty
Core Design Contradiction:
Loss of informationVSDifficulty of detecting and measuring

Solution Approach 1:

The patent segments the high-dimensional feature space by using tree-based models that recursively partition the covariate space. This segmentation approach handles wide data with many covariates by breaking down the complex multidimensional space into manageable segments, making treatment effect detection feasible even with numerous features.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The ensemble model framework introduces additional dimensional processing by combining multiple model perspectives and approaches. This dimensional transformation allows the system to navigate complex high-dimensional covariate spaces more effectively, converting the difficulty of handling many features into a manageable multi-perspective analysis.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Data Source

PatentUS20250372212A1Machine learning-based method and system for identifying subpopulations in clinical studies
Publication Date: 2025.12.04 PHASEV TRIALS LTD
  • US20250372212A1 patent drawing
  • US20250372212A1 patent drawing

AI summary

Disclosed is method and system for identifying treatment subpopulations within a patient population of a clinical study, by applying a causal ensemble model configured to output an ensemble Conditional Average Treatment Effect (eCATE).